| Pharmaceutical active ingredients: |
| Physostigmine |
| Available forms, composition and doses of Cogmine Eserine: |
| N / A |
| Cogmine Eserine medical category: |
| Human:Parasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01EB05 - PhysostigmineV03AB19 - Physostigmine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Codylin | Pholcodine | Unidentified Pharmaceutical Company |
| Coenbione | Vitamin B1 (Cocarboxylase) | Unidentified Pharmaceutical Company |
| Coenzymate | Vitamin B1 (Cocarboxylase) | Unidentified Pharmaceutical Company |
| Coforin | Pentostatin | Unidentified Pharmaceutical Company |
| Cogesic | Acetaminophen; Hydrocodone Bitartrate | Unidentified Pharmaceutical Company |
| Cogoxin | Digoxin | Unidentified Pharmaceutical Company |
| Cohasal-IH | Alginic Acid (Alginate Sodium) | Unidentified Pharmaceutical Company |
| Cohidrate | Chloral Hydrate | Unidentified Pharmaceutical Company |
| Co-Hydeltra | Prednisolone | Unidentified Pharmaceutical Company |
| Cohydrin | Dihydrocodeine | Unidentified Pharmaceutical Company |